| Value | ₹4.61 Cr |
|---|
BSE filing, NSE: BIRLACORPN. Summary written from the filing by ALFA Finder's alert engine.
Birla Corporation Ltd: key numbers
- Share price
- ₹800.65
- Market cap
- ₹6,165 Cr
- Revenue (annual)
- ₹9,656 Cr
- Net profit (annual)
- ₹557.6 Cr
- P/E (TTM)
- 12.3×Sector 33.1×
- Promoter holding
- 62.90%+0.00% QoQ
- FII holding
- 5.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Birla Corporation Ltd
All →Birla Corporation Earnings Call Transcript: Key Takeaways
Management reports a modest and subdued quarter due to high fuel prices and depressed pricing in central India.
Birla Corporation Debt & Borrowing: ₹250 Cr
Birla Corporation board approved enabling resolution for issuing up to Rs.250 Crore of listed secured/unsecured NCDs on private placement. Funds will be raised through debt within overall borrowing limits.
- Value
- ₹250.0 Cr
- Execution
- As may be decided by the Authorised Person (tenure not fixed)
Birla Corporation Results Update
Birla Corporation reported September quarter consolidated revenue of ₹2,441 Cr, up 9.3% YoY, but net profit fell 58.9% to ₹37 Cr. The release cites weak cement prices, higher input costs and rainfall disruption.
Birla Corporation Q2 FY27 Results: Net Profit ₹37.5 Cr, Down 58.6% YoY
Birla Corporation Ltd reported revenue from operations of ₹2,415 Cr (+9.5% YoY) and net profit of ₹37.5 Cr (-58.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹37.5 Cr · -58.6% YoY
Birla Corporation Board Meeting Date
Birla Corporation's board meeting is scheduled for 31 October 2026 to review Q1/H1 results and consider NCD private placement. No monetary values disclosed in this advance notice.
Birla Corporation Other Announcement
Birla Corporation Limited has filed its quarterly shareholding pattern report for the period ended September 30, 2026, as required under SEBI regulations.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.